chr22-45344560-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_148674.5(SMC1B):c.3704G>A(p.Arg1235His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,610,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_148674.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMC1B | NM_148674.5 | c.3704G>A | p.Arg1235His | missense_variant | 25/25 | ENST00000357450.9 | NP_683515.4 | |
SMC1B | NM_001291501.2 | c.3482G>A | p.Arg1161His | missense_variant | 23/23 | NP_001278430.1 | ||
SMC1B | XM_011530144.3 | c.3581G>A | p.Arg1194His | missense_variant | 25/25 | XP_011528446.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMC1B | ENST00000357450.9 | c.3704G>A | p.Arg1235His | missense_variant | 25/25 | 5 | NM_148674.5 | ENSP00000350036.4 | ||
SMC1B | ENST00000404354.3 | c.3482G>A | p.Arg1161His | missense_variant | 23/23 | 1 | ENSP00000385902.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000602 AC: 15AN: 249276Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135270
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1458654Hom.: 0 Cov.: 29 AF XY: 0.0000317 AC XY: 23AN XY: 725840
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at